Boutique CRO As a boutique consulting firm with experience across C-suite roles, Sarbanes-Oxley, FDA pathways, and 510(k)/PMA submissions, Bethesda Group is positioned to offer strategic regulatory and market-entry support to small and mid-stage diagnostic companies seeking to accelerate clinical validation, regulatory clearance, and marketplace launch.

FDA & CDx Expertise Leveraging a track record of 60+ LDTs, 40+ CDx/diagnostic trials, and 100+ patent filings, the company can target diagnostics developers aiming to optimize regulatory strategies, reimbursement pathways, and instrument/assay integration, offering end-to-end support from development through commercialization.

Funding & Compliance With a history of raising substantial private and public funding and hands-on experience implementing compliance frameworks, Bethesda Group can assist growth-stage diagnostics firms in preparing investor-ready milestones, governance setups, and SOX-compliant financial controls to attract and retain investment.

Market Readiness The combined focus on health economics and reimbursement positions Bethesda Group to help clients quantify value propositions, build payer engagement plans, and shorten time to reimbursement, appealing to companies seeking faster market access and favorable coverage decisions.

Strategic Partnerships Targeting small and mid-stage diagnostics and investment groups, Bethesda Group can serve as a trusted advisor for partnership development with pharma collaborators, contract research organizations, and potential acquirers, enabling smoother collaborations and go-to-market scaling.